Monday, September 14, 2026 – Thursday, September 17, 2026, VIRTUAL
Early registration discount deadline: August 14.
Harvard will provide a discount of 10% for groups of 5, and 20% discount for groups of 10 or more. Please contact tuccello@mgh.harvard.edu for the discount codes.
The “41st Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, including: angiogenesis, metastasis, immunology, metabolism, microbiome, chronobiology, cancer-neuroscience, chimeric antigen receptor (CAR) T-cell therapies, and integrating physical sciences, and AI in oncology. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal of this course is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench and in the clinic.
The course will return to a four-day virtual format. Learning formats will include didactic lectures, trainee-led Q&A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.